Sex Differences in the Relation between Comorbidities and Prognosis in Hospitalized Patients with COVID-19

Table 2

Frequency of comorbidities in discharged and deceased hospitalized patients with positive real-time reverse-transcription polymerase chain reaction test results for COVID-19.

Discharged	Women (n = 1,707)	Men (n = 1,991)	value
DM	332(19.4)	274(13.8)	<0.0001
Hypertension	326(19.1)	268(13.5)	<0.0001
CHD	269(15.8)	256(12.9)	0.012
CRD	102(6.0)	102(5.1)	0.258
Cancer	37(2.2)	40(2.0)	0.736
CKD	51(3.0)	67(3.4)	0.515
Deceased	Women (n = 289)	Men (n = 369)
DM	77(26.6)	78(21.1)	0.099
CHD	72(24.9)	78(21.1)	0.252
Hypertension	65(22.5)	58(15.7)	0.027
CRD	38(13.1)	34(9.2)	0.109
Cancer	17(5.9)	22(6.0)	0.966
CKD	15(5.2)	24(6.5)	0.479

RT-PCR, real-time reverse-transcription polymerase chain reaction; CHD, coronary heart disease; DM, diabetes mellitus; CRD, chronic respiratory disease; CKD, chronic kidney disease.